Cold waves with dipping temperatures, along with severe air pollution, are driving a sharp rise in heart and respiratory ...

According to the India Meteorological Department, the cold spell is expected to persist over the next few days, with severe ...

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

AirNexis Therapeutics is a clinical-stage biotech company developing novel therapeutic drugs for the treatment of COPD patients. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

This article is developed and funded by Chiesi Ltd. Dr Sooj has been paid an honorarium for his author contribution. I’M Dr Suraj Kukadia, known as Dr Sooj, an NHS GP who has seen how life-changing ...

WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...

Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...

Miami (August 21, 2025) – Prioritizing communications between patients and health care providers and increasing patient education about chronic obstructive pulmonary disease (COPD) could help improve ...